(Q35164797)

6 August 2017

1 reference

title

Gene therapy for cardiovascular angiogenesis (English)

1 reference

6 August 2017

0 references

Larry J Diaz-Sandoval

series ordinal

1

1 reference

6 August 2017

Douglas W Losordo

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Expert Opinion on Biological Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

599-616

1 reference

Gene therapy for restenosis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Reversal of experimental diabetic neuropathy by VEGF gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Prospects for gene therapy for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Direct myocardial revascularization and angiogenesis--how many patients might be eligible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Assessment of risks associated with cardiovascular gene therapy in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Therapeutic angiogenesis for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Enhanced revascularization of the ischemic limb by angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Isolation of a tumor factor responsible for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Unhealthy effects of atmospheric temperature and pressure on the occurrence of myocardial infarction and coronary deaths. A 10-year survey: the Lille-World Health Organization MONICA project (Monitoring trends and determinants in cardiovascular dise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

50th anniversary historical article. Heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac performance in a pacing model of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

In vitro differentiation of murine embryonic stem cells. New approaches to old problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Age-dependent impairment of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Morphology of the endothelium over atherosclerotic plaques in human coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Reciprocal relation between VEGF and NO in the regulation of endothelial integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo. Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene ex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Vascular endothelial growth factor enhances atherosclerotic plaque progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Human gene therapy: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.599

21 January 2018

Identifiers

DOI

10.1517/14712598.3.4.599

1 reference

6 August 2017

1 reference